Verification Study of Ciclosporin for Atopic Dermatitis

Summary

To assess the efficacy and safety of oral OL27-400MEPC 3 mg/kg/day (2-5 mg/kg/day) in 2 divided doses daily for 8 weeks to patients with severe adult atopic dermatitis. THIS STUDY IS NOT ENROLLING PATIENTS IN THE UNITED STATES

Timeline

Start

2004-05

Primary completion

2005-03

Completion

—

Drugs

Indications